No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
ALKS Alkermes
- 29.040
- +0.290+1.01%
Close Jan 3 16:00 ET
- 29.040
- 0.0000.00%
Post 16:34 ET
4.70BMarket Cap14.67P/E (TTM)
29.280High28.660Low1.19MVolume28.770Open28.750Pre Close34.50MTurnover0.77%Turnover Ratio13.83P/E (Static)161.80MShares32.88052wk High3.64P/B4.46BFloat Cap22.90052wk Low--Dividend TTM153.46MShs Float98.500Historical High--Div YieldTTM2.16%Amplitude3.550Historical Low29.046Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Alkermes to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Declining Stock and Solid Fundamentals: Is The Market Wrong About Alkermes Plc (NASDAQ:ALKS)?
Mizuho Securities Maintains Alkermes(ALKS.US) With Buy Rating, Announces Target Price $40
Alkermes Prepares for New Flexibility Post Credit Termination
Analysts Conflicted on These Healthcare Names: Talkspace (TALK), Centene (CNC) and Alkermes (ALKS)
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), DocGo (DCGO) and Alkermes (ALKS)
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.